Company Name: Foundation Medicine, Inc.    

Foundation Medicine, Inc. provides a molecular information platform that is designed to analyze specimens for cancer. The company’s products are used by physicians as well as drug developers. The company’s clinical assays include:

  • FoundationOne (solid tumors)
  • Foundationone Heme (hematologic malignancies)

Ticker Symbol: FMI (NASDAQ)

Company Website:

Social Media: Foundation Medicine LinkedIn

Headquarters: Cambridge, MA